Improving the Transparency of the Pharmaceutical Supply Chain through the Adoption of Quick Response (QR) Code, Internet of Things (IoT), and Blockchain Technology: One Result: Ending the Opioid Crisis

Authors

  • Justin D. Evans

DOI:

https://doi.org/10.5195/tlp.2019.227

Abstract

Over the past two years, Americans in nearly every state have suffered adverse effects from counterfeit medications, many of whom have died. The main culprit is Fentanyl-tainted counterfeit opiates which often lead to fatal overdoses. The increasing epidemic of counterfeit prescription medications extends beyond social classes, gender, race, and age. For instance, pop star Prince recently overdosed on counterfeit Hydrocodone containing synthetic Fentanyl. Shockingly, one in ten medications sold in developing countries are counterfeit; either containing incorrect doses of active ingredients or containing toxic contaminants retained from the production process. The popularity of counterfeit medications stems from cheaper costs, but also because of the ease with which these counterfeit products can be purchased. While the blockchain has gained its fame from Bitcoin, its potential implications are far reaching. In this paper, I propose the use of QR code and the IoT (Internet of Things) sensor devices leveraging the blockchain for increased transparency of the pharmaceutical supply chain and manufacturing process. The data collected from the devices would then be transferred to the blockchain, enabling consumers to use an app to verify the provenance of their medication.

Author Biography

Justin D. Evans

Justin Evans is a Juris Doctor Candidate for the Class of 2019, Michigan State University; M.S. 2014, Vanderbilt University; B.S. 2011, Fayetteville State University. He has been previously published in the Journal of Business, Entrepreneurship & the Law. The author would like to thank Bruce Bean, Professor at Michigan State University of Law, for his encouragement and insight in advising the author on the article. Joe Koenig and Martin Luther IV for your assistance for editing. Finally, the author would like to thank Danielle Roberson for her unwavering support of the author in any and everything he sets his mind to.

Downloads

Published

2019-03-07

How to Cite

Evans, J. D. (2019). Improving the Transparency of the Pharmaceutical Supply Chain through the Adoption of Quick Response (QR) Code, Internet of Things (IoT), and Blockchain Technology: One Result: Ending the Opioid Crisis. Pittsburgh Journal of Technology Law & Policy, 19(1). https://doi.org/10.5195/tlp.2019.227

Issue

Vol. 19 No. 1 (2019)

Section

Articles

License


Authors who publish with this journal agree to the following terms:

    1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.

    2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.

    3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons 4.0 License (Attribution-Noncommercial-No Derivative Works), or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
      1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
      2. Noncommercial—other users (including Publisher) may not use this Work for commercial purposes;
      3. No Derivative Works—other users (including Publisher) may not alter, transform, or build upon this Work,with the understanding that any of the above conditions can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.

    4. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.

    5. Authors are permitted and encouraged to post online a pre-publication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.

    6. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.

    7. The Author represents and warrants that:

      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
         
    8. The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.